Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin vs Ibuprofen for Superficial Thrombophlebitis
NCT00264381Phase 4Completed
- Sponsor
- University of Oklahoma
- Start
- Oct 2002
- Primary completion
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of dalteparin in superficial thrombophlebitis (SVT), sponsored by University of Oklahoma. Started Oct 2002; status: completed.
02
Drugs
dalteparin
03
Conditions
superficial thrombophlebitis (SVT)
Beyond the preview
Go deeper on NCT00264381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00264381.